3.91
Neuronetics Inc stock is traded at $3.91, with a volume of 507.07K.
It is down -1.01% in the last 24 hours and down -11.74% over the past month.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
See More
Previous Close:
$3.95
Open:
$3.92
24h Volume:
507.07K
Relative Volume:
0.51
Market Cap:
$257.36M
Revenue:
$69.23M
Net Income/Loss:
$-33.10M
P/E Ratio:
-3.3136
EPS:
-1.18
Net Cash Flow:
$-39.26M
1W Performance:
-2.01%
1M Performance:
-11.74%
6M Performance:
+291.00%
1Y Performance:
+105.79%
Neuronetics Inc Stock (STIM) Company Profile
Name
Neuronetics Inc
Sector
Industry
Phone
877-600-7555
Address
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
STIM
Neuronetics Inc
|
3.91 | 262.62M | 69.23M | -33.10M | -39.26M | -1.18 |
![]()
ABT
Abbott Laboratories
|
133.58 | 228.44B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
105.26 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
382.64 | 143.93B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
82.98 | 103.43B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
78.22 | 43.99B | 5.54B | 4.18B | 623.10M | 7.00 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-13-24 | Downgrade | William Blair | Outperform → Mkt Perform |
Oct-13-21 | Downgrade | BTIG Research | Buy → Neutral |
Oct-13-21 | Downgrade | William Blair | Outperform → Mkt Perform |
Jan-22-21 | Upgrade | William Blair | Mkt Perform → Outperform |
Feb-06-20 | Initiated | BTIG Research | Buy |
Jul-24-18 | Initiated | Canaccord Genuity | Buy |
View All
Neuronetics Inc Stock (STIM) Latest News
Neuronetics reports annual meeting results By Investing.com - Investing.com Canada
Neuronetics reports annual meeting results - Investing.com Australia
Neuronetics Holds Annual Meeting, Elects Directors - TipRanks
Transcranial Magnetic Stimulators (TMS) Market to Set - openPR.com
Neuronetics' SWOT analysis: stock outlook brightens post-merger By Investing.com - Investing.com UK
Neuronetics’ SWOT analysis: stock outlook brightens post-merger By Investing.com - Investing.com South Africa
Neuronetics’ SWOT analysis: stock outlook brightens post-merger - Investing.com
Neuronetics Posts Strong Revenue Growth in Q1 2025 - MSN
Insider Sell: Stephen Furlong Sells 200,000 Shares of Neuronetics Inc (STIM) - GuruFocus
Why We Think Neuronetics, Inc.'s (NASDAQ:STIM) CEO Compensation Is Not Excessive At All - simplywall.st
Neuronetics (STIM) Introduces Annual TMS Therapy Awareness Day | - GuruFocus
Neuronetics Launches First Inaugural National TMS Therapy Awaren - GuruFocus
Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month - The Manila Times
Neuronetics Announces Inducement Awards for New Team Members - MSN
Q2 Earnings Forecast for Neuronetics Issued By William Blair - Defense World
Neuronetics, Inc. (NASDAQ:STIM) Released Earnings Last Week And Analysts Lifted Their Price Target To US$6.83 - Yahoo
Neuronetics, Inc. (NASDAQ:STIM) Just Reported And Analysts Have Been Lifting Their Price Targets - simplywall.st
Neuronetics, Inc. (NASDAQ:STIM) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Neuronetics Q1 2025 misses EPS, stock drops 22% - Investing.com Nigeria
Neuronetics Inc (STIM) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges - Yahoo Finance
Neuronetics Inc (STIM) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges By GuruFocus - Investing.com Canada
Neuronetics Reports Strong Q1 2025 Growth - TipRanks
Neuronetics: Q1 Earnings Snapshot - CTPost
Neuronetics Q1 2025 Earnings Call Transcript - MarketBeat
Neuronetics, Inc. Provides Earnings Guidance for the Second Quarter of 2025 - marketscreener.com
Neuronetics Q1 2025 slides: Combined entity targets profitability by Q3 amid 84% revenue growth - Investing.com Canada
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Neuronetics (STIM) Surpasses Q1 Revenue Expectations with $32M | - GuruFocus
Neuronetics Reports First Quarter 2025 Financial and Operating R - GuruFocus
Neuronetics (STIM) Surpasses Q1 Revenue Expectations with $32M | STIM Stock News - GuruFocus
Neuronetics Inc (STIM) Q1 2025 Earnings: Revenue Surpasses Estimates at $32.0M, EPS Misses at $(0.21) - GuruFocus
Neuronetics reports inducement grant - Medical Buyer
Neuronetics Announces CFO Retirement Amidst Q1 Growth - TipRanks
Neuronetics, Inc. SEC 10-Q Report - TradingView
Neuronetics Reports First Quarter 2025 Financial and Operating Results - The Manila Times
Neuronetics Reports 84% Revenue Growth in Q1 2025 Driven by Greenbrook Acquisition - Nasdaq
Renaissance Technologies LLC Has $255,000 Position in Neuronetics, Inc. (NASDAQ:STIM) - Defense World
JPMorgan Chase & Co. Increases Stock Holdings in Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5 - GuruFocus
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | STIM Stock News - GuruFocus
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Neuronetics Expands Team with 4,500 Share RSU Package for Three New Strategic Hires - Stock Titan
Transcranial Magnetic Stimulator Market Generated - openPR.com
Neuronetics, Inc.'s (NASDAQ:STIM) 30% Jump Shows Its Popularity With Investors - simplywall.st
Neuronetics Inc Stock (STIM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Neuronetics Inc Stock (STIM) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Furlong Stephen | EVP, CFO and Treasurer |
May 13 '25 |
Sale |
4.16 |
6,540 |
27,206 |
410,053 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):